These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1137392)

  • 1. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.
    Watanakunakorn C; Bannister T; Glotzbecker C
    Antimicrob Agents Chemother; 1975 Mar; 7(3):381-5. PubMed ID: 1137392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.
    Vuye A; Pijck J; Soep H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):422-32. PubMed ID: 1259401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.
    Overturf GD; Ressler RL; Marengo PB; Wilkins J
    Antimicrob Agents Chemother; 1975 Sep; 8(3):305-10. PubMed ID: 1167042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I; Dickert H; Machka K
    Infection; 1979; 7(5):231-6. PubMed ID: 389804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative inhibitory activity of BL-S640 and two other cephalosporins.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    J Antibiot (Tokyo); 1975 Aug; 28(8):590-3. PubMed ID: 239917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.
    Leitner F; Buck RE; Misiek M; Pursiano TA; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):298-305. PubMed ID: 1137381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disk susceptibility studies with cefazolin and cephalothin.
    Actor P; Guarini J; Uri J; Dickson J; Pauls JF; Weisbach JA
    Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological properties of a new cephalosporin, BL-S 339: 7-(phenylacetimidoyl-aminoacetamido)-3-(2-methyl-1,3,4-thiadiazol-5-ylthiomethyl)ceph-3-em-4-carboxylic acid.
    Misiek M; Pursiano TA; Leitner F; Price KE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):40-8. PubMed ID: 4790575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640).
    Stilwell GA; Adams HG; Turck M
    Antimicrob Agents Chemother; 1975 Dec; 8(6):751-3. PubMed ID: 813573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
    Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
    Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefatrizine activity compared with that of other cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):209-12. PubMed ID: 426514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins.
    Blackwell CC; Freimer EH; Tuke GC
    Antimicrob Agents Chemother; 1976 Aug; 10(2):288-92. PubMed ID: 984771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.